Mahindra Manulife Manufacturing Fund
The Scheme seek to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies engaged in manufacturing theme.
Growthvine rating: 1/5 — ranked #150 of 184 in category.
Fund basics
| Category | Equity: Thematic |
|---|
| NAV | ₹10.29 (as of 2026-10-01) |
|---|
| AUM | ₹673 Cr |
|---|
| Expense ratio | 2.04% |
|---|
| Riskometer | Very High |
|---|
| Fund manager | Navin Matta |
|---|
| Exit load | 0.5% for redemption within 3 months |
|---|
Performance & risk
| Standard deviation | 0.00% |
|---|
| Max drawdown | −23.72% |
|---|
| Alpha | 0 |
|---|
| Beta | 0 |
|---|
Over 5 years, captured 90.6% of NIFTY India Manufacturing's upside and 95.4% of its downside.
Market cap allocation
| Large cap | 44.8% |
|---|
| Mid cap | 14.6% |
|---|
| Small cap | 40.6% |
|---|
Concentration
| Top 5 holdings | 22.1% |
|---|
| Top 10 holdings | 37.5% |
|---|
| Total holdings | 52 |
|---|
Top holdings
- Divis Laboratories Ltd. — 5.2%
- Mahindra & Mahindra Ltd. — 4.7%
- SHRIRAM PISTONS & RINGS LTD — 4.4%
- Sun Pharmaceutical Industries Ltd. — 4.1%
- Triparty Repo — 3.8%
- Reliance Industries Ltd — 3.8%
- Hindalco Industries Ltd. — 3.5%
- TATA STEEL LIMITED — 3.4%
- Bajaj Auto Limited — 3.1%
- Bharat Electronics Ltd. — 2.8%
Top sectors
- Automobile — 24.9%
- Industrial Products — 17.7%
- Pharma & Biotech — 13.1%
Calendar-year track record
| Year | Return | Quartile | Category rank |
|---|
| 2026 (partial) | 3.0% | Q2 | #46 of 167 |
| 2025 | 6.0% | Q2 | #51 of 132 |